4//SEC Filing
Thompson Elizabeth H.Z. 4
Accession 0001415889-24-021243
CIK 0001070494other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 6:05 PM ET
Size
8.0 KB
Accession
0001415889-24-021243
Insider Transaction Report
Form 4
Thompson Elizabeth H.Z.
EVP, Head of Research & Dev
Transactions
- Award
Stock Option (Right to Buy)
2024-08-12+324,582→ 324,582 totalExercise: $15.29Exp: 2034-08-11→ Common Stock (324,582 underlying) - Award
Restricted Stock Units
2024-08-12+64,544→ 64,544 total→ Common Stock (64,544 underlying)
Footnotes (3)
- [F1]25% of the shares subject to the Stock Option will vest and become exercisable on July 29, 2025. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
- [F3]50% of the restricted stock units vest on July 29, 2026 and 25% vest on each of July 29, 2027 and July 29, 2028.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001861477
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 6:05 PM ET
- Size
- 8.0 KB